THIS IS AN ONLINE E LOG BOOK TO DISCUSS OUR PATIENT'S DE-IDENTIFIED HEALTH DATA SHARED AFTER TAKING HIS SIGNED INFORMED CONSENT. HERE WE DISCUSS OUR PATIENT'S PROBLEMS THROUGH SERIES OF INPUTS FROM AVAILABLE GLOBAL ONLINE COMMUNITY EXPERTS WITH AN AIM TO SOLVE THOSE PATIENT'S CLINICAL PROBLEMS WITH COLLECTIVE CURRENT BEST EVIDENCE BASED INPUTS.
[8:39 pm, 24/04/2026] PPM 1: @PaJR Health wonder if you will be able to prepare this patient's timeline from the handwritten notes here?
[8:39 pm, 24/04/2026] PaJR Health: *CLINICAL TIMELINE: 75M*
*Diagnosis:* Neurovascular/Neurodegenerative Disorder, Metabolic Syndrome, CKD, CAD, Hypothyroidism.
*CHRONOLOGICAL PROGRESSION*
*2016 – 2023: Baseline Comorbidities*
* *2016:* Diagnosed with Hypertension and Hypothyroidism (on Thyronorm 100mcg).
* *2023:* Diagnosed with Hyponatremia (on Tolvaptan 15mg) and CKD (on Sod. Bicarbonate and Febuxostat).
* *2023 (Specific Event):* Suffered a fall leading to suspected Subdural Hematoma (SDH). Advised burr hole surgery (not performed). Started on Antiepileptics (Brivaracetam 100mg, Sodium Valproate 500mg).
* *Post-Fall 2023:* Developed left hemiparesis and mouth deviation; recovered within one month.
*October 2025 – March 2026: Neurological Decline*
* *Oct 2025:* Developed tremors (worse while holding objects), gait instability (inability to walk independently), and effortful, non-fluent speech.
* *Feb 13, 2026:* Diagnosed with CAD (EF 62%, RWMA in LAD territory). Started on NTG 2.6mg and Antiplatelets (Clopidogrel + Aspirin).
* *Last 3 Months:* Walking only with support; generalized weakness.
*Acute Presentation (April 17–18, 2026)*
* *April 17 (Afternoon):* Sudden onset of dysphagia (unable to swallow food), followed by vomiting and intense coughing.
* *April 17 (Evening):* Developed altered sensorium.
* *April 18 (01:30 PM):* Vomited again.
* *April 18 (03:30 PM):* Developed "violent" continuous cough and Shortness of Breath (SOB).
* *April 18 (05:00 PM):* Patient became comatose.
* *April 18 (DOA):* Admitted to current facility. Initial saturation drop noted after a water feed at a previous center.
*CURRENT MEDICATIONS*
* *Neurological:* Brivaracetam 100mg BD, Sodium Valproate 500mg BD.
* *Cardiovascular:* NTG 2.6mg BD, Clopidogrel + Aspirin 75/75mg, Rosuvastatin 20mg, Cinod 10mg.
* *Metabolic/Renal:* Thyronorm 100mcg OD, Tolvaptan 15mg BD, Sodium Bicarbonate 1000mg BD, Febuxostat 40mg OD.
💡 *CLINICAL NOTE*
The acute deterioration (dysphagia followed by violent coughing and rapid desaturation) is highly suggestive of *Aspiration Pneumonia* secondary to underlying neurodegenerative bulbar weakness. Given the history of "violent" coughing post-feed and subsequent coma, immediate airway protection and management of potential pulmonary edema/aspiration are critical.
[8:58 pm, 24/04/2026] PPM 1: Well done 👏
Slight corrections:
All his problems began with a left hemiparesis on 2016, which is when he was also found to have hypothyroidism and Hypertension.
He recovered from his hemiparesis in 3 months in 2016 itself.
Was found to have hyponatremia since 2020 and is on tolvaptan.
Both his parents had tremors after they became more than 60 years old and gradually developed paralysis and became bed ridden and died within a year!
Similar symptoms started with him since October 2025 when he developed tremors and gradual inability to walk preceded with knee pains due to his osteoarthritis again possibly related to his metabolic syn that precipitated his right middle cerebral artery stroke in 2016.
He appears to be having a complex mixture of genetic and metabolic syn related factors driving his current illness manifestations? Genetic neurodegenerative disorder overlapping with metabolic syn related neurovascular cerebral degeneration?
[8.58 pm, 24/04/2026] PaJR Health: **UPDATED CLINICAL TIMELINE: 75M****Diagnosis:** Overlap of Genetic Neurodegeneration and Metabolic Syndrome-driven Neurovascular Disease.
**CHRONOLOGICAL PROGRESSION**
**2016: The Sentinel Event**
* **Right MCA Stroke:** Presented with left hemiparesis; achieved full recovery within 3 months.
* **Comorbidities:** Concurrent diagnosis of Hypertension and Hypothyroidism (started on Thyronorm 100mcg).
**2020 – 2023: Metabolic & Renal Progression**
* **2020:** Onset of chronic Hyponatremia (managed with Tolvaptan).
* **2023:** Diagnosed with CKD (on Sod. Bicarbonate and Febuxostat).
* **2023 (Trauma):** Fall leading to suspected Subdural Hematoma (SDH); started on Antiepileptics (Brivaracetam, Sodium Valproate).
**October 2025 – March 2026: Neurodegenerative Decline**
* **Oct 2025:** Onset of tremors and gait instability (preceded by knee pain from Osteoarthritis).
* **Feb 13, 2026:** CAD diagnosis (EF 62%, RWMA in LAD territory).
* **Progression:** Gradual transition to walking only with support; non-fluent speech.
**Acute Presentation (April 17–18, 2026)**
* **April 17:** Sudden dysphagia, vomiting, and intense coughing.
* **April 18:** Rapid neurological decline to coma following a water feed; suspected **Aspiration Pneumonia**.
**GENETIC CONTEXT & FAMILY HISTORY**
* **Paternal/Maternal History:** Both parents developed tremors after age 60, followed by rapid paralysis and death within one year.
* **Clinical Correlation:** The patient’s current presentation (tremors, gait instability, and bulbar dysfunction/dysphagia) mirrors this familial pattern, suggesting a hereditary neurodegenerative component (e.g., atypical Parkinsonism or late-onset genetic leukoencephalopathy) overlapping with his established neurovascular risk factors.
💡 **CLINICAL NOTE**
The "double hit" of a 2016 MCA stroke and a strong hereditary neurodegenerative history likely accelerated his current bulbar failure. The acute aspiration event on April 18 is the immediate life-threatening complication of this long-term neurological decline
[8.48 am, 25/04/2026] PPM 1: Current summary and plan attached
@PaJR Health can you help convert and integrate these hand written notes on current local doctor's impression and treatment plan into a brief imrad summary using the previous timeline for this patient? I shall also share the chest X-rays and HRCT images of the patient that reveals his current shortness of breath was perhaps a result of acute pulmonary edema due to his chronic heart failure through metabolic syn along with some right lobar lung fibrosis probably as a result of a past indolent lung infection
[8:48 am, 25/04/2026] PaJR Health: *IMRAD CLINICAL SUMMARY: 75M*
*INTRODUCTION*
A 75-year-old male with a complex clinical profile involving a 2016 Right MCA stroke (fully recovered), chronic metabolic syndrome (HTN, Hypothyroidism, CKD Stage V, CAD), and a significant family history of late-onset neurodegeneration. The patient presented with acute neurological and respiratory decline on April 18, 2026, following a period of progressive tremors and gait instability that began in October 2025.
*METHODS (CURRENT CLINICAL STATUS)*
* *Vitals (24/04/26):* Temp 98.9°F, PR 77 bpm, RR 18 cpm, SpO2 98% on 4L O2.
* *Neurological:* Altered sensorium secondary to Hypoxic Encephalopathy and Chronic Hyponatremia. History of Seizure Disorder (gliotic focus).
* *Respiratory:* Type I Respiratory Failure secondary to Aspiration Pneumonitis.
* *Imaging (Clinical Correlation):* HRCT/CXR suggest acute pulmonary edema (metabolic/cardiac origin) and right lobar lung fibrosis (likely post-inflammatory).
*RESULTS (DIAGNOSTIC IMPRESSION)*
1. *Sepsis & Septic Shock (Resolved):* Secondary to aspiration.
2. *Hypoxic Encephalopathy:* Driving the current altered sensorium.
3. *Chronic Conditions:* CKD (Stage V), CAD, Hypothyroidism, Hypertension, and Chronic Hyponatremia.
4. *Complications:* Grade II Bed Sore; Chronic Meningitis (under investigation).
*DISCUSSION & TREATMENT PLAN*
The patient’s current state is a "triple hit" of acute aspiration, chronic metabolic failure (CKD/CAD), and a hereditary neurodegenerative decline. The focus is on stabilization, infection control, and neuro-protection.
*Current Management Plan (as of 24/04/26):*
* *Respiratory:* O2 inhalation (4-6L) to maintain SpO2 95-98%; Nebulization with Ipravent, Budecort, and Mucomix.
* *Infection Control:* Tab. Faropenem 300mg BD, Tab. Clindamycin.
* *Neuro/Seizure Prophylaxis:* Tab. Levipil 500mg BD, Tab. Sodium Valproate 500mg BD.
* *Cardio/Metabolic:* Tab. Thyroxine 75mcg OD, Tab. Met-XL 25mg OD, Tab. Cinod 10mg BD, Tab. Dytor 10mg BD, Tab. Ecosprin-AV 75/10mg HS.
* *Supportive Care:* Salt restriction (<2g/day), RT feeds (high protein), Enoxaparin 30mg SC OD (DVT prophylaxis), Chest Physiotherapy, and Neosporin for bed sore.
💡 *CLINICAL NOTE*
The transition from a stable neurovascular baseline (2016 stroke recovery) to rapid decline (2025-2026) strongly supports the user's hypothesis of a genetic neurodegenerative overlap. The current "Chronic Meningitis" note in the local doctor's impression warrants careful monitoring, as it may further complicate the hypoxic encephalopathy.
[8:53 am, 25/04/2026] PPM 1: Can you reconcile this patient's neurodegenerative disorder presentation with the earlier published neurodegenerative disorder patients from NKP here? 👇
[8:53 am, 25/04/2026] PaJR Health: The clinical presentation of this 75-year-old patient aligns significantly with the thematic findings of the Narketpally case series (Dhavala et al., 2022; PMID: 35874938), which explored the "common clinical ground" between movement disorders and organic psychopathology in a rural South Indian cohort.
*RECONCILIATION WITH NARKETPALLY COHORT THEMES*
*1. Movement Disorders as Early Clinical Markers*
* *Narketpally Finding:* The study identified movement disorders (tremors, gait instability) as early indicators of underlying organic psychopathology or neurodegeneration.
* *Patient Correlation:* This patient’s decline was heralded by tremors and gait instability in October 2025, which preceded the rapid bulbar failure (dysphagia) and altered sensorium (hypoxic encephalopathy) in April 2026.
*2. The "Common Ground" of Psychiatric & Motor Symptoms*
* *Narketpally Finding:* A consistent association was found between movement disorders and psychiatric/cognitive symptoms, suggesting shared pathways of degeneration.
* *Patient Correlation:* The patient’s non-fluent speech and eventual coma (altered sensorium) represent the "organic psychopathology" described in the study, emerging from the same neurodegenerative substrate that caused his tremors.
*3. Complex Multimorbidity & Local Environmental Factors*
* *Narketpally Finding:* The cohort often presented with "clinical complexity," including comorbidities like fluorosis and metabolic syndrome, which are prevalent in the Narketpally region.
* *Patient Correlation:* This patient exemplifies this complexity, where a *genetic predisposition* (familial tremors/paralysis) is accelerated by *metabolic syndrome* (CKD, CAD, HTN) and a *neurovascular event* (2016 MCA stroke).
*4. The "Double Hit" Hypothesis*
* *Narketpally Finding:* The study emphasizes that while patients start on a common ground, they develop different courses based on individual risk factors.
* *Patient Correlation:* The patient’s course was uniquely aggressive due to the "double hit" of hereditary neurodegeneration (mirroring his parents' rapid decline) and metabolic-driven neurovascular disease.
*CLINICAL SYNTHESIS*
The Narketpally study concludes that movement disorders are not isolated events but are "early clinical markers of organic psychopathology." In this patient, the tremors were the sentinel sign of a failing neurological system that, when stressed by an acute metabolic/respiratory event (aspiration/pulmonary edema), led to rapid global collapse.
🔗 *Reference:* [Integrated case-based clinical approach in understanding pathways, complexities, pitfalls and challenges in neurodegenerative disorders](https://pubmed.ncbi.nlm.nih.gov/35874938/) (PMID: 35874938)
[9:29 am, 25/04/2026] PPM 4: Pl check
Clindamycin dose
[9:30 am, 25/04/2026] PPM 1: 👆 just found that no dose has been mentioned here @PPM3
[10:35 am, 25/04/2026] PPM 3: 600mg twice daily sir
[10:46 am, 25/04/2026] PPM 1: Corrected in today's note
[10:47 am, 25/04/2026] PPM 1: Update:
The patient has been non hypoxemic since 24 hours yesterday.
Persistent crepitations are from his previous right lung fibrosis as well illustrated in his chest imaging after admission @PPM3
From the patient's imaging, evidence of old right lower lobar fibrosis with recent pleural effusion due to pulmonary edema
No comments:
Post a Comment